Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Martin Latterich at BioScale; Norman Hardman at Integrated Diagnostics; and More

Premium

BioScale said this week that it has appointed Martin Latterich as chief scientific officer.

Latterich is also chief scientific officer and a board member of the non-profit Nicholas Conor Institute for Pediatric Cancer Research. He has also been a professor at the Proteogenomics Research Institute for Systems Medicine and has held senior management positions at several companies including Diversa and Illumina.


Integrated Diagnostics announced this week that it has named Norman Hardman president of its new InDi Imaging division (see story this issue).

Hardman is currently non-executive director of Chelsea Therapeutics. He was previously the president and CEO of biotech consulting firm Oxalis Partners. Before that he held senior management positions at companies including Amicus Therapeutics, Enzon Pharmaceuticals, Onyx Pharmaceuticals, and GeneMedicine.

InDi also appointed University of California, Los Angeles professor Michael Phelps to the division as an advisor. The inventor of PET imaging technology, Phelps is the chair of the UCLA Department of Molecular and Medical Pharmacology and director of the Crump Institute for Molecular Imaging.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.